Strategy Focus. Equity Strategy: Growth at a Reasonable Price. United States

Transcription

1 Strategy Focus N O V E M B E R United States Equity Strategy: Growth at a Reasonable Price This report is prepared on a monthly basis according to the criteria listed below. These criteria are pre-set and will not be adjusted in this or future reports. Accordingly, the securities listed have not been individually reviewed by the author nor is the author recommending these securities. Simon Kong Morgan Stanley Smith Barney Capital Markets New York Focus This report identifies those stocks in the research coverage universe of Morgan Stanley & Co. LLC (Morgan Stanley) and Citi Investment Research & Analysis (CIRA) which exceed three key S&P 500 capitalization weighted statistics: Dividend Yield Price to Earnings Ratio Long Term Projected EPS Growth Rate Criteria - Please note past performance is not a guarantee of future performance. Stocks must be Overweight or Equal-Weight rated by Morgan Stanley Research and/or Buy (1) or Neutral (2) Rated by Citi Investment Research & Analysis Dividend Yield > S&P 500 Index Yield Price Earnings Ratio < S&P 500 Index P/E Projected Long Term EPS Growth Estimate > S&P 500 Index Universe Average Projected Long Term EPS Growth Estimate Closing price $3 Reminder This list should be used as a starting point only. This is not a research report. Please note past performance is not a guarantee of future performance. Please ask your Financial Advisor for a copy of current fundamental research on those stocks which appear to be of interest. Past performance is not a guarantee of future performance. Growth investing does not guarantee a profit or eliminate risk. The stocks of these companies can have relatively high valuations. Because of these high valuations, an investment in a growth stock can be more risky than an investment in a company with more modest growth expectations. Information provided herein has been obtained from outside sources that are deemed to be reliable. However, Morgan Stanley Smith Barney has not independently verified them and we make no guarantees, express or implied, as to their accuracy or completeness or as to whether they are current. This material has been prepared for informational purposes only and is not an offer to buy or sell or a solicitation of any offer to buy or sell any security or other financial instrument or to participate in any trading strategy. This is not a research report and has not been prepared by the research departments of Citigroup Global Markets Inc. and its affiliates or Morgan Stanley & Co. LLC. This material was prepared by Morgan Stanley Smith Barney sales, trading or other non-research personnel. Past performance is not necessarily a guide to future performance. Please see additional important information and Page 1

2 Growth at a Reasonable Price MS MS CIRA Mktcap Price Curr. Yr. Dividend First Call Rating Industry Rating ($ mil) 11/4/2011 Fwd P/E Yield Lt GrRate SPX S&P 500 (Operating Basis) 1, % AHT Ashford Hospitality Trust OW In-Line % ACI Arch Coal Inc. EW Cautious 1 3, % MPC Marathon Petroleum Corp. OW Attractive 1H 13, % STLD Steel Dynamics Inc. EW In-Line 1 2, % RIG Transocean Ltd. OW Attractive 1 16, % ATLS Atlas Energy L.P. OW In-Line 1, % GES Guess? Inc. EW In-Line 1 2, % OZM Och-Ziff Capital Mgmt Group LLC. 1 1, % TEL TE Connectivity Ltd. 1 15, % CSX CSX Corp. OW Attractive 1 22, % PMT PennyMac Mortgage Invest. Trust % TUP Tupperware Brands Corp. OW In-Line 3, % TWX Time Warner Inc. EW Attractive 1 34, % PRU Prudential Financial Inc. OW Attractive 2 25, % LAZ Lazard Ltd. 1 3, % GE General Electric Co , % ARLP Alliance Resource Partners L.P. 1 2, % NTRI Nutrisystem Inc. 1H % SPLS Staples Inc. OW Cautious 2 10, % DRI Darden Restaurants Inc. OW In-Line 1 6, % RE Everest Re Group Ltd. EW In-Line 1 4, % ITW Illinois Tool Works Inc. 1 23, % BX Blackstone Group L.P. 1 5, % INTC Intel Corp , % WMT Wal-Mart Stores Inc. EW In-Line 1 198, % MSFT Microsoft Corp. OW In-Line 1 220, % AVP Avon Products Inc. EW In-Line 1 7, % IVZ INVESCO Ltd. 1 9, % Source: Citi Investment Research, Morgan Stanley Smith Barney & Factset Research Systems 2

3 Morgan Stanley & Co. LLC Research Ratings Definitions Morgan Stanley uses a relative rating system using terms such as Overweight, Equal-weight, Not-Rated, or Underweight. Morgan Stanley does not assign ratings of Buy, Hold or Sell to the stocks covered. Overweight, Equal-weight, Not-Rated and Underweight are not the equivalent of buy, hold and sell. Investors should carefully read the definitions of all ratings used in Morgan Stanley Research. In addition, since Morgan Stanley Research contains more complete information concerning the analyst's view, investors should carefully read Morgan Stanley Research, in its entirety, and not infer the contents from the ratings alone. In any case, ratings (or research) should not be used or relied upon as investment advice. An investor's decision to buy or sell a stock should depend on individual circumstances (such as the investor's existing holdings) and other considerations. Overweight (OW): The stock's total return is expected to exceed the average total return of the analyst's industry (or industry team's) coverage universe, on a risk-adjusted basis, over the next months. Equal-weight (EW): The stock's total return is expected to be in line with the average total return of the analyst's industry (or industry team's) coverage universe, on a risk-adjusted basis, over the next months. Underweight (U): The stock's total return is expected to be below the average total return of the analyst's industry (or industry team's) coverage universe, on a risk-adjusted basis, over the next months. Not-Rated (NR): Currently, the analyst does not have adequate conviction about the stock's total return relative to the average total return of the analyst's industry (or industry team's) coverage universe, on a risk-adjusted basis, over the next months. In addition to analyst stock ratings, Morgan Stanley provides the analyst s industry views: Attractive (A): Performance of industry coverage universe over the next 12 to18 months is expected to be attractive versus the relevant broad In Line (I): Cautious (C): Performance of industry coverage universe over the next 12 to18 months is expected to be in line with the relevant broad Performance of industry coverage universe over the next 12 to18 months is viewed with caution versus the relevant broad Citi Investment Research & Analysis Research Ratings Definitions CIRA s stock recommendations include an investment rating and an optional risk rating to highlight high risk stocks. The risk rating takes into account both price volatility and fundamental criteria. Stocks will either have no risk rating or a High risk rating assigned. Investment Ratings: CIRA's investment ratings are Buy (1), Neutral (2) and Sell (3). CIRA s ratings are a function of analyst expectations of expected total return ( ETR ) and risk. ETR is the sum of the forecast price appreciation (or depreciation) plus the dividend yield for a stock within the next 12 months. CIRA s investment rating definitions are: Buy (1) ETR of 15% or more or 25% or more for High risk stocks; and Sell (3) for negative ETR. Any CIRA covered stock not assigned a Buy or a Sell is a Neutral (2). For stocks rated Neutral (2), if a CIRA analyst believes that there are insufficient valuation drivers and/or investment catalysts to derive a positive or negative investment view, they may elect with the approval of CIRA management not to assign a target price and, thus, not derive an ETR. CIRA Analysts may place covered stocks Under Review in response to exceptional circumstances (e.g. lack of information critical to the analyst's thesis) affecting the company and / or trading in the company's securities (e.g. trading suspension). As soon as practically possible, the CIRA analyst will publish a note re-establishing a rating and investment thesis. To satisfy regulatory requirements, CIRA corresponds Under Review and Neutral to Hold in its ratings distribution table for CIRA s 12-month fundamental rating system. However, CIRA reiterates that it does not consider Under Review to be a recommendation. Prior to October 7, 2011, CIRA used a different stock recommendation system. Please refer to a CIRA research report for a complete description of CIRA s prior and current recommendation system and for more information regarding CIRA. 3

4 * Benchmarks include North America: S&P 500, Latin America: relevant MSCI country index, Europe: MSCI Europe, Japan: TOPIX and Asia: relevant MSCI country index. For important disclosures (including copies of historical disclosures) regarding the securities and/or companies that are the subject of this material, please contact Morgan Stanley Smith Barney Research, 522 Fifth Ave., New York, N.Y , Attention: Research Management. In addition, the same important disclosures, with the exception of the historical disclosures, are contained on the Firm's disclosure website at Historical disclosures will be provided upon request back to June 1, Important Information and Qualifications This material was prepared by sales, trading or other non-research personnel of Morgan Stanley Smith Barney LLC (together with its affiliates, Morgan Stanley Smith Barney or the firm ). Morgan Stanley Smith Barney was formed pursuant to a Joint Venture between Citigroup Inc. and Morgan Stanley & Co. LLC ( Morgan Stanley ). This material was not produced by a research analyst of Morgan Stanley, Citigroup Global Markets Inc., ( Citigroup ) or Morgan Stanley Smith Barney, although it may refer to a Morgan Stanley, Citigroup, or Morgan Stanley Smith Barney research analyst or report. Unless otherwise indicated, these views (if any) are the author s and may differ from those of the aforementioned research departments or others in the firms. The securities/instruments discussed in this material may not be suitable or appropriate for all investors. The appropriateness of a particular investment or strategy will depend on an investor s individual circumstances and objectives. This material does not provide individually tailored investment advice or offer tax, regulatory, accounting or legal advice. By submitting this document to you, Morgan Stanley Smith Barney is not advising you to take any particular action based on the information, opinions or views contained in this document. Prior to entering into any proposed transaction, recipients should determine, in consultation with their own investment, legal, tax, regulatory and accounting advisors, the economic risks and merits, as well as the legal, tax, regulatory and accounting characteristics and consequences, of the transaction. This information is not intended to, and should not, form a primary basis for any investment decision. You should consider this material among other factors in making an investments decision. Unless stated otherwise, the material contained herein has not been based on a consideration of any individual client circumstances and as such should not be considered to be a personal recommendation. This material was not intended or written to be used, and it cannot be used by any taxpayer, for the purpose of avoiding penalties that may be imposed on the taxpayer under U.S. federal tax laws. Each taxpayer should seek advice based on the taxpayer s particular circumstances from an independent tax advisor. The firm is not acting as a fiduciary under either the Employee Retirement Income Security Act of 1974, as amended ( ERISA ) or under section 4975 of the Internal Revenue Code of 1986 as amended ( Code ) in providing this material. Morgan Stanley Smith Barney is not acting as a municipal advisor and the opinions or views contained herein are not intended to be, and do not constitute, advice within the meaning of Section 975 of the Dodd-Frank Wall Street Reform and Consumer Protection Act. This material was prepared by or in conjunction with Morgan Stanley Smith Barney trading desks that may deal as principal in or own or act as market maker or liquidity provider for the securities/instruments (or related derivatives) mentioned herein and may trade them in ways different from those discussed in this material. The trading desk may have accumulated a position in the subject securities/instruments based on the information contained herein. Trading desk materials are not independent of the proprietary interests of the firm, which may conflict with your interests. We may also perform or seek to perform investment banking services for the issuers of the securities/instruments mentioned herein. The author(s) principally responsible for the preparation of this material receive compensation based upon various factors, including quality and accuracy of their work, firm revenues (including trading and capital markets revenues), client feedback and competitive factors. Morgan Stanley Smith Barney is involved in many businesses that may relate to companies, securities or instruments mentioned in this material. These businesses include market making and specialized trading, risk arbitrage and other proprietary trading, fund management, investment services and investment banking. This material has been prepared for informational purposes only and is not an offer to buy or a solicitation of any offer to sell any security/instrument, or to participate in any trading strategy. Any such offer would be made only after an investor had completed an independent investigation of the securities, instruments or transactions, and received all information required to make their own investment decision, including, where applicable, a review of any prospectus, prospectus supplement, offering circular or memorandum describing such security or instrument. That information would supersede this material and contain material information not contained herein and to which prospective participants are referred. This material is based on public information as of the specified date, and may be stale thereafter. We have no obligation to tell you when information herein is stale or may change. We make no express or implied representation or warranty with respect to the accuracy or completeness of this material, nor are we obligated to provide updated information on the securities/instruments mentioned herein. Any securities referred to in this material may not have been registered under the U.S. Securities Act of 1933, as amended, and, if not, may not be offered or sold absent an exemption therefrom. Recipients are required to comply with any legal or contractual restrictions on their purchase, holding, sale, exercise of rights or performance of obligations under any security/instrument or otherwise applicable to any transaction. The value of and income from investments may vary because of changes in interest rates, foreign exchange rates, default rates, prepayment rates, prices of securities/instruments, market indexes, operational or financial conditions of companies or other factors. There may be time limitations on the exercise of options or other rights in securities/instruments transactions. Past performance is not necessarily a guide to future performance. Estimates of future performance are based on assumptions that may not be realized. Actual events may differ from those assumed and changes to any assumptions may have a material impact on any projections or estimates. Other events not taken into account may occur and may significantly affect the projections or estimates. Certain assumptions may have been made for modeling purposes only to simplify the presentation and/or calculation of any projections or estimates, and Morgan Stanley Smith Barney does not represent that any such assumptions will reflect actual future events or that all assumptions have been considered or stated. Accordingly, there can be no assurance that estimated returns or projections will be realized or that actual returns or performance results will not materially differ from those estimated herein. The trademarks and service marks contained herein are the property of their respective owners. Third-party data providers make no warranties or representations, express or implied relating to the accuracy, completeness, or timeliness of the data they provide and shall not have liability for any damages of any kind relating to such data. Unless otherwise specifically indicated, all information in these materials with respect to any third party not affiliated with Morgan Stanley Smith Barney has been provided by, and is the sole responsibility of, such third party and has not been independently verified by Morgan Stanley Smith Barney, its affiliates or any other independent third party. This material may not be sold or redistributed without the prior written consent of Morgan Stanley Smith Barney. This material is not for distribution 4

5 outside the United States of America. Morgan Stanley Smith Barney LLC is a registered broker-dealer, not a bank. Unless otherwise specifically disclosed to you in writing, investments and services offered through Morgan Stanley Smith Barney LLC, member SIPC, are not insured by the FDIC, are not deposits or other obligations of, or guaranteed by, banks and involve investment risks, including possible loss of principal amount invested. GP P-M03/ Morgan Stanley Smith Barney LLC. Member SIPC 5